Karzinosarkome des Uterus (maligne Müller-Mischtumoren des Uterus, maligne mesodermale Mischtumoren, maligne gemischte mesenchymale Tumoren)

作者: Mathias K. Fehr , Daniel Fink

DOI: 10.1007/978-3-642-17076-8_4

关键词:

摘要: Neueren Erkenntnissen nach sind Karzinosarkome epithelialen Ursprungs. Sie werden dennoch aus Grunden der besseren Ubersichtlichkeit und zu deren besserer Abgrenzung nicht unter den anderen Malignomen des Uterus, sondern eigens in diesem Kapitel behandelt.

参考文章(38)
Edward V. Hannigan, Roger B. Yandell, Esperanza M. Tiamson, Belur S. Bhagavan, Tung V. Dinh, Richard E. Slavin, Mixed müllerian tumors of the uterus: a clinicopathologic study. Obstetrics & Gynecology. ,vol. 74, pp. 388- 392 ,(1989)
Francis J. Major, John A. Blessing, Steven G. Silverberg, C. Paul Morrow, William T. Creasman, John L. Currie, Edgardo Yordan, Mark F. Brady, Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group study Cancer. ,vol. 71, pp. 1702- 1709 ,(1993) , 10.1002/CNCR.2820710440
Khadra Galaal, Esther van der Heijden, Keith Godfrey, Raj Naik, Ali Kucukmetin, Andrew Bryant, Nagindra Das, Alberto D Lopes, Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma Cochrane Database of Systematic Reviews. ,vol. 2013, ,(2013) , 10.1002/14651858.CD006812.PUB3
E. Tanner, K. Long, Q. Zhou, R. Brightwell, G. Gardner, N. Abu-Rustum, M. Leitao, Y. Sonoda, R. Barakat, A. Iasonos, D. Chi, Does operative start time impact the frequency of complete gross resection in patients undergoing primary cytoreduction for advanced serous ovarian carcinoma Gynecologic Oncology. ,vol. 121, ,(2011) , 10.1016/J.YGYNO.2011.02.027
Kristina Gerszten, Clare Faul, Sophia Kounelis, Quingshou Huang, Joseph Kelley, Mirka W. Jones, The Impact of Adjuvant Radiotherapy on Carcinosarcoma of the Uterus Gynecologic Oncology. ,vol. 68, pp. 8- 13 ,(1998) , 10.1006/GYNO.1997.4901
M. J. Evans, I. D. Miller, N. E.I. Langlois, H. C. Kitchener, Is there an association between long-term tamoxifen treatment and the development of carcinosarcoma (malignant mixed Müllerian tumor) of the uterus? International Journal of Gynecological Cancer. ,vol. 5, pp. 310- 313 ,(1995) , 10.1046/J.1525-1438.1995.05040310.X
Gunjal Garg, Michael Kruger, Carl Christensen, Gunter Deppe, Eugene P. Toy, Stage III uterine carcinosarcoma: 2009 International Federation of Gynecology and Obstetrics Staging System and Prognostic Determinants. International Journal of Gynecological Cancer. ,vol. 21, pp. 1606- 1612 ,(2011) , 10.1097/IGC.0B013E31822265AD
Michael Callister, Lois M Ramondetta, Anuja Jhingran, Thomas W Burke, Patricia J Eifel, Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. International Journal of Radiation Oncology Biology Physics. ,vol. 58, pp. 786- 796 ,(2001) , 10.1016/S0360-3016(03)01561-X
Philip J. DiSaia, Gregory P. Sutton, John A. Blessing, Neil Rosenshein, Guy Photopulos, Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (A Gynecologic Oncology Group Study) American Journal of Obstetrics and Gynecology. ,vol. 161, pp. 309- 312 ,(1989) , 10.1016/0002-9378(89)90507-3